Paige A. Taylor, Ph.D, FAAPM

Peer-Reviewed Articles

1. Faddegon B, Descovich M, Chen K, Ramos-Méndez J, Iii MR, Wahl N, Taylor P, Griffin K, Lee C. A digital male pelvis phantom series showing anatomical variations over the course of fractionated radiotherapy treatment. Med Phys. e-Pub 2023. PMID: 38071746.
2. Zou W, Zhang R, Schüler E, Taylor PA, Mascia AE, Diffenderfer ES, Zhao T, Ayan AS, Sharma M, Yu SJ, Lu W, Bosch WR, Tsien C, Surucu M, Pollard-Larkin JM, Schuemann J, Moros EG, Bazalova-Carter M, Gladstone DJ, Li H, Simone CB, Petersson K, Kry SF, Maity A, Loo BW, Dong L, Maxim PG, Xiao Y, Buchsbaum JC. Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps. Int J Radiat Oncol Biol Phys 116(5):1202-1217, 2023. e-Pub 2023. PMID: 37121362.
3. Taylor PA, Miles E, Hoffmann L, Kelly SM, Kry SF, Sloth Møller D, Palmans H, Akbarov K, Aznar MC, Clementel E, Corning C, Effeney R, Healy B, Moore A, Nakamura M, Patel S, Shaw M, Stock M, Lehmann J, Clark CH. Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison. Radiother Oncol 182:109494, 2023. e-Pub 2023. PMID: 36708923.
4. Taylor, P. A., Miles, E., Hoffmann, L., Kelly, S. M., Kry, S. F., Sloth Møller, D., Palmans, H., Akbarov, K., Aznar, M. C., Clementel, E., Corning, C., Effeney, R., Healy, B., Moore, A., Nakamura, M., Patel, S., Shaw, M., Stock, M., Lehmann, J. & Clark, C. H.,. Prioritizing clinical trial quality assurance for photon and protons: A failure modes and effect analysis (FMEA) comparison. Radiotherapy and Oncology 182(109494), 2023.
5. Mehrens H, Taylor P, Alvarez P, Kry S. Analysis of Performance and Failure Modes of the IROC Proton Liver Phantom. Int J Part Ther 10(1):23-31, 2023. e-Pub 2023. PMID: 37823015.
6. Zhu XR, Li Y, Yang M, Whitaker TJ, Taylor PA, Zhang X, Poenisch F, Sahoo N, Liao Z, Chang JY. Stereotactic body proton therapy for early stage non-small cell lung cancer - Technical challenges and solutions: The MD Anderson experience. J Radiosurg SBRT 9(1):75-82, 2023. PMID: 38029015.
7. Maroongroge S, Pinnix CC, Wallington DG, Taylor PA, Zhu D, Guadagnolo BA, Smith BD, Yu JB, Ballas LK. In Reply to Smith et al. Int J Radiat Oncol Biol Phys 113(3):696-697, 2022. PMID: 35777400.
8. Taylor PA, Moran JM, Jaffray DA, Buchsbaum JC. A roadmap to clinical trials for FLASH. Med Phys 49(6):4099-4108, 2022. e-Pub 2022. PMID: 35366339.
9. Maroongroge S, Wallington DG, Taylor PA, Zhu D, Guadagnolo BA, Smith BD, Yu JB, Ballas LK. Geographic access to radiation therapy facilities in the United States. Int J Radiat Oncol Biol Phys 112(3):600-610, 2022. e-Pub 2021. PMID: 34762972.
10. Taylor PA, Lowenstein J, Followill D, Kry SF. The Value of On-Site Proton Audits. Int J Radiat Oncol Biol Phys 112(4):1004-1011, 2022. e-Pub 2021. PMID: 34780973.
11. Mehrens H, Nguyen T, Edward S, Hartzell S, Glenn M, Branco D, Hernandez N, Alvarez P, Molineu A, Taylor P, Kry S. The current status and shortcomings of stereotactic radiosurgery. Neurooncol Adv 4(1):vdac058, 2022. e-Pub 2022. PMID: 35664554.
12. Hartzell S, Guan F, Taylor P, Peterson C, Taddei P, Kry S. Uncertainty in tissue equivalent proportional counter assessments of microdosimetry and RBE estimates in carbon radiotherapy. Phys Med Biol 66(15), 2021. e-Pub 2021. PMID: 34252894.
13. Kry SF, Lye J, Clark CH, Andratschke N, Dimitriadis A, Followill D, Howell R, Hussein M, Ishikawa M, Kito S, Kron T, Lee J, Michalski J, Filippo Monti A, Reynaert N, Taylor P, Venables K, Xiao Y, Lehmann J. Report dose-to-medium in clinical trials where available; a consensus from the global Harmonisation group to maximize consistency. Radiother Oncol. e-Pub 2021. PMID: 33741471.
14. Branco D, Kry S, Taylor P, Rong J, Zhang X, Frank S, Followill D. Evaluation of image quality of a novel computed tomography metal artifact management technique on an anthropomorphic head and neck phantom. Phys Imaging Radiat Oncol 17:111-116, 2021. e-Pub 2021. PMID: 33898789.
15. Lin L, Taylor PA, Shen J, Saini J, Kang M, Simone CB, Bradley JD, Li Z, Xiao Y. NRG oncology survey of monte carlo dose calculation use in US proton therapy centers. Int J Part Ther 8(2):73-81, 2021. e-Pub 2021. PMID: 34722813.
16. Branco D, Kry S, Taylor P, Zhang X, Rong J, Frank S, Followill D. Dosimetric impact of commercial CT metal artifact reduction algorithms and a novel in-house algorithm for proton therapy of head and neck cancer. Med Phys. e-Pub 2020. PMID: 33176003.
17. Taylor PA, Alvarez PE, Mehrens H, Followill DS. Failure modes in IROC photon liver phantom irradiations. Pract Radiat Oncol. e-Pub 2020. PMID: 33271351.
18. Hua CH, Vern-Gross TZ, Hess CB, Olch AJ, Alaei P, Sathiaseelan V, Deng J, Ulin K, Laurie F, Gopalakrishnan M, Esiashvili N, Wolden SL, Krasin MJ, Merchant TE, Donaldson SS, FitzGerald TJ, Constine LS, Hodgson DC, Haas-Kogan DA, Mahajan A, Laack NN, Marcus KJ, Taylor PA, Ahern VA, Followill DS, Buchsbaum JC, Breneman JC, Kalapurakal JA. Practice patterns and recommendations for pediatric image-guided radiotherapy: A Children's Oncology Group report. Pediatr Blood Cancer:e28629. e-Pub 2020. PMID: 32776500.
19. Branco D, Kry S, Taylor P, Rong J, Zhang X, Peterson C, Frank S, Followill D. Development of a stereoscopic CT metal artifact management algorithm using gantry angle tilts for head and neck patients. J Appl Clin Med Phys. e-Pub 2020. PMID: 32506820.
20. Edward SS, Alvarez PE, Taylor PA, Molineu HA, Peterson CB, Followill DS, Kry SF. Differences in the patterns of failure between IROC lung and spine phantom irradiations. Pract Radiat Oncol. e-Pub 2020. PMID: 32413413.
21. Mehrens H, Taylor P, Followill DS, Kry SF. Survey results of 3D-CRT and IMRT quality assurance practice. J Appl Clin Med Phys. e-Pub 2020. PMID: 32351006.
22. Arjomandy B, Taylor P, Ainsley C, Safai S, Sahoo N, Pankuch M, Farr JB, Yong Park S, Klein E, Flanz J, Yorke ED, Followill D, Kase Y. AAPM task group 224: Comprehensive proton therapy machine quality assurance. Med Phys 46(8):e678-e705, 2019. e-Pub 2019. PMID: 31125441.
23. Yock AD, Mohan R, Flampouri S, Bosch W, Taylor PA, Gladstone D, Kim S, Sohn J, Wallace R, Xiao Y, Buchsbaum J. Robustness analysis for external beam radiation therapy treatment plans: describing uncertainty scenarios and reporting their dosimetric consequences. Pract Radiat Oncol 9(4):200-207, 2019. e-Pub 2018. PMID: 30562614.
24. Kang Y, Shen J, Liu W, Taylor PA, Mehrens HS, Ding X, Hu Y, Tryggestad E, Keole SR, Schild SE, Wong WW, Fatyga M, Bues M. Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons. Radiat Oncol 14(1):108, 2019. e-Pub 2019. PMID: 31208439.
25. Wang P, Tang S, Taylor PA, Cummings DE, Janson M, Traneus E, Sturgeon JD, Lee AK, Chang C. Clinical examination of proton pencil beam scanning on a moving anthropomorphic lung phantom. Med Dosim 44(2):122-129, 2019. e-Pub 2018. PMID: 29759487.
26. Huang S, Souris K, Li S, Kang M, Barragan Montero AM, Janssens G, Lin A, Garver E, Ainsley C, Taylor P, Xiao Y, Lin L. Validation and application of a fast Monte Carlo algorithm for assessing the clinical impact of approximations in analytical dose calculations for pencil beam scanning proton therapy. Med Phys 45(12):5631-5642, 2018. e-Pub 2018. PMID: 30295950.
27. Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Kry SF. Reference dosimetry data and modeling challenges for Elekta accelerators based on IROC-Houston site visit data. Med Phys 45(5):2337-2344, 2018. e-Pub 2018. PMID: 29537634.
28. Branco D, Taylor P, Zhang H, Li H, Guindani M, Followill D. An anthropomorphic head and neck quality assurance phantom for credentialing of intensity-modulated proton therapy. International Journal of Particle Therapy, 2018.
29. Lewis DJ, Taylor PA, Followill DS, Sahoo N, Mahajan A, Stingo FC, Kry SF. A new anthropomorphic pediatric spine phantom for proton therapy clinical trial credentialing. Int J Part Ther 4(4):20-27, 2018. e-Pub 2018. PMID: 30214913.
30. Kry SF, Dromgoole L, Alvarez P, Leif J, Molineu A, Taylor P, Followill DS. Radiation therapy deficiencies identified during on-site dosimetry visits by the Imaging and Radiation Oncology Core Houston Quality Assurance Center. Int J Radiat Oncol Biol Phys 99(5):1094-1100, 2017. e-Pub 2017. PMID: 29029890.
31. Taylor PA, Kry SF, Followill DS. Pencil beam algorithms are unsuitable for proton dose calculations in lung. Int J Radiat Oncol Biol Phys 99(3):750-756, 2017. e-Pub 2017. PMID: 28843371.
32. Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Kry SF. Agreement between institutional measurements and treatment planning system calculations for basic dosimetric parameters as measured by the Imaging and Radiation Oncology Core-Houston. Int J Radiat Oncol Biol Phys 95(5):1527-1534, 2016. e-Pub 2016. PMID: 27315667.
33. Martin MT, Telebak E, Taylor PA, Volozhina O. Development of a specialty medication prior-authorization service at an urban academic medical center. Am J Health Syst Pharm 73(15):1174-1179, 2016. PMID: 27440624.
34. Taylor PA, Kry SF, Alvarez P, Keith T, Lujano C, Hernandez N, Followill DS. Results from the Imaging and Radiation Oncology Core Houston's anthropomorphic phantoms used for proton therapy clinical trial credentialing. Int J Radiat Oncol Biol Phys 95(1):242-248, 2016. e-Pub 2016. PMID: 27084644.
35. Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Stingo FC, Kry SF. Technical Report: Reference photon dosimetry data for Varian accelerators based on IROC-Houston site visit data. Med Phys 43(5):2374, 2016. PMID: 27147349.
36. Cho J, Summers PA, Ibbott GS. An anthropomorphic spine phantom for proton beam approval in NCI-funded trials. J Appl Clin Med Phys 15(3):252-265, 2014. e-Pub 2014. PMID: 24892351.
37. Grant RL, Summers PA, Neihart JL, Blatnica AP, Sahoo N, Gillin MT, Followill DS, Ibbott GS. Relative stopping power measurements to aid in the design of anthropomorphic phantoms for proton radiotherapy. J Appl Clin Med Phys 15(2):4523, 2014. e-Pub 2014. PMID: 24710437.
38. Moyers MF, Ibbott GS, Grant RL, Summers PA, Followill DS. Independent dose per monitor unit review of eight U.S.A. proton treatment facilities. Med Phys 41(1):012103-01 - 012103-5, 2014. PMID: 24387521.
39. Iqbal K, Gillin M, Summers PA, Dhanesar S, Gifford KA, Buzdar SA. Quality assurance evaluation of spot scanning beam proton therapy with an anthropomorphic prostate phantom. Br J Radiol 86(1031):20130390, 2013. e-Pub 2013. PMID: 24049129.
40. Dhanesar S, Sahoo N, Kerr M, Taylor MB, Summers P, Zhu XR, Poenisch F, Gillin M. Quality assurance of proton beams using a multilayer ionization chamber system. Med Phys 40(9):092102-1 - 092102-9, 2013. PMID: 24007171.
41. Tanyi JA, He T, Summers PA, Mburu RG, Kato CM, Rhodes SM, Hung AY, Fuss M. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: Role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys 5(78):1579-1585, 2010. e-Pub 2010. PMID: 20472357.
42. Tanyi JA, Summers PA, McCracken CL, Chen Y, Ku LC, Fuss M. Implications of a high-definition multileaf collimator (HD-MLC) on treatment planning techniques for stereotactic body radiation therapy (SBRT): a planning study. Radiat Oncol 4:22, 2009. e-Pub 2009. PMID: 19591687.